Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

708

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Glargine (HOE901) [Lantus]

100 Units/ml solution for injection in a pre-filled pen SoloStar® (3 ml)

DRUG

Glimepiride

tablets of 1 and 2 mg

DRUG

human insulin [NPH]

100 IU/ml suspension for injection in a prefilled pen OptiSet® (3 ml)

Trial Locations (87)

1205

Investigational Site Number 756001, Geneva

4545

Investigational Site Number 784-001, Dubai

10000

Investigational Site Number 203004, Prague

Investigational Site Number 203005, Prague

10330

Investigational Site Number 764004, Bangkok

10400

Investigational Site Number 764001, Bangkok

11018

Investigational Site Number 250-003, Narbonne

12120

Investigational Site Number 764005, Pathum Thani

13100

Investigational Site Number 250-002, Aix-en-Provence

16300

Investigational Site Number 203007, Prague

17176

Investigational Site Number 752001, Stockholm

21120

Investigational Site Number 752002, Malmo

22361

Investigational Site Number 752004, Lund

26601

Investigational Site Number 203003, Beroun

30000

Investigational Site Number 764006, Nakhonratchasima

33200

Investigational Site Number 250-005, Bordeaux

37001

Investigational Site Number 203008, České Budějovice

37007

Investigational Site Number 203011, České Budějovice

39701

Investigational Site Number 203009, Moravský Písek

40002

Investigational Site Number 764003, Khon Kaen

42086

Investigational Site Number 484009, Pachuca

44150

Investigational Site Number 484003, Guadalajara

44650

Investigational Site Number 484005, Guadalajara

46001

Investigational Site Number 203010, Liberec

50002

Investigational Site Number 764002, Chiang Mai

51162

Investigational Site Number 752003, Skene

53701

Investigational Site Number 203001, Chrudim III

54800

Investigational Site Number 250-004, Jarny

64710

Investigational Site Number 484001, Monterrey

67000

Investigational Site Number 250-006, Strasbourg

69501

Investigational Site Number 203006, Hodonín

72190

Investigational Site Number 484002, Puebla City

75301

Investigational Site Number 203002, Hranice I - Mesto

81102

Investigational Site Number 703003, Bratislava

82606

Investigational Site Number 703007, Bratislava

93401

Investigational Site Number 703008, Levice

97517

Investigational Site Number 703005, Banská Bystrica

194354

Investigational Site Number 643-004, St-Ptetersburg

195257

Investigational Site Number 643-002, Saint Petersburg

625046

Investigational Site Number 643-007, Tyumen

202110340

Investigational Site Number 076-007, Rio de Janeiro

60115-282

Investigational Site Number 076-001, Fortaleza

60430-370

Investigational Site Number 076-006, Fortaleza

90035-170

Investigational Site Number 076-005, Porto Alegre

01221-000

Investigational Site Number 076-004, São Paulo

01244-030

Investigational Site Number 076-003, São Paulo

04024-002

Investigational Site Number 076-002, São Paulo

Unknown

Investigational Site Number 818001, Menoufiya

Investigational Site Number 414001, Kuwait City

Investigational Site Number 642001, Bucharest

Investigational Site Number 642002, Bucharest

Investigational Site Number 642009, Cluj-Napoca

Investigational Site Number 642003, Craiova

Investigational Site Number 642005, Iași

Investigational Site Number 642010, Oradea

Investigational Site Number 642011, Oradea

Investigational Site Number 642007, Ploieşti

Investigational Site Number 642004, Reşiţa

Investigational Site Number 642008, Târgu Mureş

Investigational Site Number 642012, Timișoara

Investigational Site Number 643-001, Moscow

Investigational Site Number 643-003, Saint Petersburg

Investigational Site Number 643-006, Samara

Investigational Site Number 643-005, Saratov

Investigational Site Number 410005, Daegu

Investigational Site Number 410003, Seoul

Investigational Site Number 410004, Seoul

06600

Investigational Site Number 250-001, Antibes

06156

Investigational Site Number 380001, Perugia

042090

Investigational Site Number 484008, Pachuca

7600SZ

Investigational Site Number 528006, Almelo

7314 ET

Investigational Site Number 528005, Apeldoorn

6191JW

Investigational Site Number 528001, Beek

7909AA

Investigational Site Number 528002, Hoogeveen

9603AE

Investigational Site Number 528004, Hoogezand

3053CD

Investigational Site Number 528003, Rotterdam

80-211

Investigational Site Number 616004, Gdansk

31-262

Investigational Site Number 616003, Krakow

20-954

Investigational Site Number 616002, Lublin

41-800

Investigational Site Number 616001, Zabrze

04001

Investigational Site Number 703004, Košice

Investigational Site Number 703006, Košice

04011

Investigational Site Number 703002, Košice

03659

Investigational Site Number 703001, Martin

420-717

Investigational Site Number 410002, Gyeonggi-do

400-711

Investigational Site Number 410006, Incheon

137-701

Investigational Site Number 410001, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY